Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of April 2025. The report specifically details a transaction in the company's own shares executed under a share buyback programme announced on March 28, 2025.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity figures. It focuses exclusively on share repurchase activity.
| Metric | Value |
|---|---|
| Date of Purchase | April 25, 2025 |
| Shares Purchased | 861,136 |
| Highest Price Paid | 379.70 pence |
| Lowest Price Paid | 374.20 pence |
| Volume Weighted Average Price | 377.30 pence |
| Registered Share Capital | 9,023,600,136 ordinary shares |
| Treasury Shares Held | 4,080,205 |
| Voting Shares Outstanding | 9,019,519,931 |
Material Changes
Following the settlement of the repurchase, the number of ordinary shares with voting rights decreased to 9,019,519,931. The filing notes that this figure is relevant for shareholders determining notification requirements under the FCA's Disclosure Guidance and Transparency Rules.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on financial performance, or discussion of risks and contingencies. It is a regulatory disclosure of a completed share transaction.
Key Facts for Investor Verification
- Verify the total number of shares purchased (861,136) against the company's total buyback authorization limits.
- Confirm the updated voting share count (9,019,519,931) for compliance with disclosure thresholds.
- Review the full trade breakdown available via the provided London Stock Exchange link for granular execution details.
- Note that this filing does not contain financial performance data; refer to the most recent Form 20-F or quarterly reports for revenue and earnings.